- Home
- MNY vs MYO Comparison
MNY vs MYO Comparison
Compare MNY & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MNY | MYO |
|---|---|---|
| Founded | 2014 | 2004 |
| Country | Singapore | United States |
| Employees | 240 | N/A |
| Industry | | Industrial Specialties |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.9M | 44.8M |
| IPO Year | N/A | 2017 |
Fundamental Metrics
Financial Performance| Metric | MNY | MYO |
|---|---|---|
| Price | $0.94 | $0.96 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $4.00 | ★ $7.67 |
| AVG Volume (30 Days) | 65.3K | ★ 901.7K |
| Earning Date | 04-30-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,000,000,000.00 |
| Revenue This Year | N/A | $9.10 |
| Revenue Next Year | $19.58 | $13.59 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 40814.79 |
| 52 Week Low | $0.78 | $0.61 |
| 52 Week High | $2.40 | $2.22 |
Technical Indicators
Market Signals| Indicator | MNY | MYO |
|---|---|---|
| Relative Strength Index (RSI) | 37.76 | 39.59 |
| Support Level | $0.78 | $0.93 |
| Resistance Level | $1.03 | $0.99 |
| Average True Range (ATR) | 0.07 | 0.10 |
| MACD | 0.02 | -0.02 |
| Stochastic Oscillator | 64.00 | 17.95 |
Price Performance
Historical ComparisonAbout MNY MoneyHero Limited
MoneyHero Ltd is a tech- and AI-powered personal finance aggregation and comparison platform and a digital insurance brokerage provider in Greater Southeast Asia. It operates in Singapore, Hong Kong, Taiwan and the Philippines. Its brand portfolio includes B2C platforms MoneyHero, SingSaver, Money101, Moneymax and Seedly, as well as the B2B platform Creatory. The company has four operating and reportable segments: Hong Kong, Singapore, the Philippines, and Taiwan. The Hong Kong segment generates the majority of the revenue.
About MYO Myomo Inc.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA). Geographically, it derives maximum revenue from the United States, followed by Germany, and other international.